Ignite Creation Date:
2025-12-24 @ 2:15 PM
Ignite Modification Date:
2026-01-08 @ 9:42 PM
Study NCT ID:
NCT00686595
Status:
COMPLETED
Last Update Posted:
2023-08-09
First Post:
2008-05-27
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Study to Evaluate the Switch From Etanercept to Infliximab in Subjects With Moderate-to-Severe Psoriasis (Study P05133)
Sponsor:
Merck Sharp & Dohme LLC
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2007-10-01
Start Date Type:
ACTUAL
Primary Completion Date:
2009-10-01
Primary Completion Date Type:
ACTUAL
Completion Date:
2009-10-01
Completion Date Type:
ACTUAL
First Submit Date:
2008-05-27
First Submit QC Date:
None
Study First Post Date:
2008-05-30
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2011-01-27
Results First Submit QC Date:
None
Results First Post Date:
2011-02-24
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-07-25
Last Update Post Date:
2023-08-09
Last Update Post Date Type:
ACTUAL